Dr. CALIS B.
ActiveDr. CALIS B. has been active since 1988 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.24M and a net result of €357k. Equity is growing by ~15.9% per year across the filed fiscal years. Its solvency ranks better than 89% of 16491 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Checked score
Score 2025
91
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability87▼-2
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €200k at 30 days acceptable
Liquidity ample (current ratio 16.14; short-term debt: 6.1% and cash: 18.4% of total assets), and 6.2% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
93.8%
Return on assets
15%
Age of the figures
17 mo
neutral · Filed after the deadline
The financial year that closed on 30-04-2025 was due by 30-11-2025 and was filed on 16-12-2025, 16 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
16 d late
2024
19 d late
2023
7 d late
2022
on the day
2021
on the day
2020
on the day
2019
20 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 30-04-2026 and is due by 30-11-2026. Nothing is late today.
Companies Code · seven monthsPosition in the running window
30-04-2026 close19-09-2026 today30-11-2026 deadline
Financials · fiscal year 2025, micro schema
Equity
€2.24M▲ 5.5%
2024 · €2.12M
2019: €959k
2020: €1.07M
2021: €1.39M
2022: €1.70M
2023: €1.77M
2024: €2.12M
2019 → 2025
Total assets
€2.39M▲ 12.1%
2024 · €2.13M
2019: €999k
2020: €1.20M
2021: €1.40M
2022: €1.71M
2023: €1.91M
2024: €2.13M
2019 → 2025
Net result
€357k▲ 1.9%
2024 · €350k
2019: €278k
2020: €293k
2021: €322k
2022: €313k
2023: €323k
2024: €350k
2019 → 2025
Working capital
€2.19M▲ 6.3%
2024 · €2.06M
2019: €937k
2020: €1.05M
2021: €1.37M
2023: €1.70M
2024: €2.06M
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€1.39M-€1.70M▲ 22.5%€1.77M▲ 3.8%€2.12M▲ 19.8%€2.24M▲ 5.5%
Operating result€475k-€463k▼ 2.5%€464k▲ 0.3%€476k▲ 2.4%€480k▲ 1.0%
Net result€322k-€313k▼ 2.7%€323k▲ 3.2%€350k▲ 8.5%€357k▲ 1.9%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2022 the operating result has climbed three years in a row; 2025 is 1% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.39M
Fixed assets
€50k▼ 19.3%
Current assets
€2.34M▲ 13.1%
Equity and liabilities €2.39M
Equity
€2.24M▲ 5.5%
Debt
€149k▲ 1,702%
The debt ratio rises from 0.4% to 6.2%. Equity and debt are higher.
Key figures and ratios
EBITDA
€494k▲
2024 · €490k
Cash flow
€371k▲
2024 · €365k
Solvency
93.8%▼
2024 · 99.6%
Current ratio
16.14
Quick ratio
16.14
Debt / equity
0.07▲
2024 · 0.00
ROE
16.0%▼
2024 · 16.5%
ROA
15.0%▼
2024 · 16.5%
Interest coverage
3125.31▲
2024 · 1177.47
Debt
€149k▲
2024 · €8k
Debt ≤ 1 year
€145k▲
2024 · €5k
Income taxes
€171k▲
2024 · €167k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€2.13M€2.39M▲
Fixed assets21/28€62k€50k▼
Tangible fixed assets22/27€62k€50k▼
Plant, machinery and equipment23€1k€651▼
Furniture and vehicles24€54k€43k▼
Other tangible fixed assets26€7k€7k=
Current assets29/58€2.07M€2.34M▲
Amounts receivable within one year40/41€22k€595▼
Other amounts receivable41€22k€595▼
Current investments50/53€1.66M€1.88M▲
Cash at bank and in hand54/58€353k€440k▲
Deferred charges and accrued income490/1€35k€20k▼
Equity and liabilities
Total equity and liabilities10/49€2.13M€2.39M▲
Equity10/15€2.12M€2.24M▲
Contributions10/11€2k€2k=
Reserves13€2.12M€2.24M▲
Distributable reserves133€2.12M€2.24M▲
Amounts payable17/49€8k€149k▲
Amounts payable within one year42/48€5k€145k▲
Taxes, remuneration and social security45€5k-
Taxes450/3€5k-
Other amounts payable47/48-€145k
Accrued charges and deferred income492/3€3k€4k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€14k€14k▼
Other operating charges640/8€2k€2k▼
Gross operating margin9900€492k€497k▲
Operating profit (loss)9901€476k€480k▲
Financial income75/76B€43k€48k▲
Recurring financial income75€43k€48k▲
Financial charges65/66B€416€158▼
Recurring financial charges65€416€158▼
Profit (loss) for the period before taxes9903€518k€528k▲
Income taxes67/77€167k€171k▲
Profit (loss) for the period9904€350k€357k▲
Profit (loss) for the period to be appropriated9905€350k€357k▲
Appropriation of the result
Profit (loss) to be appropriated9906€350k€357k▲
Transfer from equity791/2-€240k
Transfer to equity691/2€350k€357k▲
To other reserves6921€350k€357k▲
Profit to be distributed694/7-€240k
Return on contributions (dividend)694-€240k
The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2025
16-12
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 16 days late
30-04
Financial
Highest result since 2019net €357k ▲1.9%
Operating result €480k, net result €357k, both a record.
2024
19-12
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 19 days late
30-04
Financial
Liquidity times 30current ratio 395.46
Current ratio from 13.27 to 395.46; short-term debt falls from €138k to €5k.
30-04
Financial
Equity above €2MEq €2.12M ▲19.8%
6 profitable years in a row build equity to €2.12M.
2023
07-12
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 7 days late
2022
30-11
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2021
30-11
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
30-04
Financial
Liquidity times 13current ratio 121.25
Current ratio from 9.25 to 121.25; short-term debt falls from €127k to €11k.
2020
30-11
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
30-04
Financial
Equity above €1MEq €1.07M ▲11.6%
2 profitable years in a row build equity to €1.07M.
2019
20-12
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 20 days late
2018
30-11
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2017
04-12
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 4 days late
2016
30-11
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Wevelgem · 1 establishment unit since 1988
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Heulestraat 508560 WevelgemGround area
891 m²
Building footprint
217 m²
Volume, LiDAR
1,267 m³
Parcel 34012C0343/00K000, Flanders · tallest building 8.9 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Heulestraat 50, 8560 Wevelgem
since 19882.230.963.871
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 34012C0343/00K000 | Flanders | 891 m² | 1 · 217 m² | 8.9 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
TIGMA
BE 0768.900.093
Lochristi · Eq €2.24M
Maison médicale du Nord
BE 0418.198.573
Schaarbeek · Eq €2.24M
Dr. Dirk Vermeulen
BE 0865.122.610
Ichtegem · Eq €2.25M
HUISARTSENPRAKTIJK DR. VANDEKERCKHOVE
BE 0834.856.828
Sint-Pieters-Leeuw · Eq €2.25M
MAXEMMA
BE 0472.718.909
Antwerpen · Eq €2.22M
Of 9,120 companies in sector 86210 we hold annual accounts for 6,336. 2,737 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded12-11-1988
Fiscal year end30-04
Activities, NACEBEL
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 37 filingsAddress and cadastre registers
Data from official sources, last processed on 17-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
2 entriesE-mail:dr.calis@pandora.be
Phone:056/41.72.72